FDA Finds Another Carcinogen in Certain Valsartan Heart Meds

FRIDAY, Sept. 14, 2018 — There’s more bad news for Americans who took certain brands of the common blood pressure medication valsartan.
The U.S. Food and Drug Administration on Thursday warned that it has found a second impurity in three lots of…
Source: Topamax